Need for transfusions falls with erythropoietin before surgery

05/9/2013 | PhysiciansBriefing.com

Patients who received human recombinant erythropoietin in the days before heart surgery needed less transfused blood, according to findings presented at a thoracic surgery meeting. The randomized prospective study looked at about 600 cardiac surgery patients. Erythropoietin is a viable but underutilized tool for patient blood management, said Dr. Luca Weltert of the European Hospital in Rome.

View Full Article in:

PhysiciansBriefing.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President - Government Products
Health Alliance Plan
Detroit, MI
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Actuary
Meridian Health Plan
Detroit, MI
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
President/Chief Executive Officer
MedCost
Winston-Salem, NC